What defines fermentation-derived proteins
Fermentation-derived proteins are ingredients made by microorganisms in a controlled vessel, in two approaches. Biomass fermentation grows the organism itself and uses it as the protein, as with single-cell protein, yeast protein and air protein. Precision fermentation programmes a host to make one specific protein, which is purified and sold, as with recombinant whey, casein, egg white and heme proteins.
Precision-fermented ingredients are defined by their target. Beta-lactoglobulin powder is specified at a minimum of 85 percent protein, recombinant ovalbumin at 81.88 to 86.06 percent across three batches, and lactoferrin above 90 percent purity. Leghemoglobin preparation is different, since at least 65 percent of its protein is heme protein and the remainder is host yeast protein.
Biomass products are defined by the organism. Single-cell protein from fungal mycelia is notified at 40 to 50 percent dry-weight protein, yeast protein at 42 to 68 percent, and the hydrogen-oxidising bacterium protein behind air protein at 73 to 80 percent. Animal-free gelatin from a fermentation-derived collagen polypeptide is specified at 80 percent minimum, completing the range.
How fermentation-derived proteins are produced
Both approaches run in stirred fermenters fed with sugar, ethanol or gases, along with nitrogen and minerals. For precision fermentation, a gene encoding the target protein is inserted into a host such as Komagataella phaffii, Trichoderma reesei or Escherichia coli, and the host secretes or accumulates the protein. Strain engineering, promoter choice and feed strategy determine titre.
Recovery separates the target from the broth. Cells are removed by centrifugation or filtration, the protein is concentrated by ultrafiltration and purified by chromatography or precipitation, then dried. Purity requirements differ: a food colour such as leghemoglobin tolerates host protein, while a milk protein replacing whey for beverages needs high purity and defined residual DNA and host protein levels.
Biomass processes skip the purification chain but add cell treatment. The harvested biomass is heat treated to lower nucleic acids, dewatered and dried or texturised. Gas fermentation, in which hydrogen-oxidising bacteria grow on carbon dioxide and hydrogen, separates protein production from agriculture. Fermented plant protein is a third route, using microbes to modify a plant substrate.
Nutrition and functionality of fermentation-derived proteins compared
Precision-fermented proteins match the amino-acid profile of the animal protein whose sequence they copy. Milk casein has a reported DIAAS of 1.17 in young children, and a recombinant casein is expected to follow the sequence, although the value was not measured for it. Animal-free gelatin, like conventional gelatin, is limited by tryptophan, with a DIAAS around 0.46.
Functionality follows the sequence as well. Recombinant beta-lactoglobulin gels and foams like whey, recombinant ovalbumin supports foaming and heat setting like egg white, and recombinant casein is aimed at cheese and yogurt analogues, where milk protein structure drives set. Leghemoglobin contributes iron-bound heme colour and meaty flavour on cooking, not bulk protein, at low dose.
Biomass proteins behave differently. Yeast protein and fungal biomass add protein with fibre and flavour, and are usually blended with other ingredients. Fermented plant protein, such as fungal-fermented substrates ranging from 13.9 to 86.5 percent protein, can show improved flavour or digestibility depending on the microbe. Limiting residues include threonine and sulphur amino acids for yeast protein.
Regulatory picture for fermentation-derived proteins
Rules centre on novel food and GRAS pathways. In the European Union, recombinant milk and egg proteins fall under Regulation (EU) 2015/2283 and need authorisation before sale. In the United States, FDA had no questions about notices for fermentation-derived beta-lactoglobulin, including GRN 000863 and GRN 001056, and about egg-white protein notices GRN 001104 and GRN 001249.
Casein is further behind. GRN 001228 for beta-casein was closed after the notifier asked FDA to stop evaluation, and two casein notices were pending at the last update. Singapore lists animal-free beta-lactoglobulin among approved novel foods, and approved Solein protein powder in 2022 with a 73 percent protein specification. Leghemoglobin is listed as a colour additive in 21 CFR 73.520.
Allergen labelling follows the source sequence. Recombinant whey and casein are identical to milk proteins and must be labelled as milk allergens, and recombinant ovalbumin must declare egg. Leghemoglobin derived from a soybean sequence must be labelled for soy in the United States. Host-specific data on residual protein and endotoxin accompany biomass and precision products alike.
How to choose among fermentation-derived proteins
Match the approach to the job. Precision-fermented whey, casein or egg white replace a specific animal functionality and suit dairy and egg analogues where gelation or foaming is essential. Biomass products such as yeast protein or fungal single-cell protein suit bulk protein fortification, blends and meat analogues, where cost per kilogram of protein matters more than a defined sequence.
Check market access first. Few precision-fermented ingredients have completed authorisation in every market, so buyers should confirm the legal instrument for each target country, the production strain, the specification and any use limits. A GRAS notice closed with no questions covers a specific product and intended use, and pending notices should not be treated as clearance.
Then evaluate technical and supply risks. Ask for lot data on protein purity, host protein, residual DNA, endotoxin and allergen status, and run application trials in the real recipe. Confirm capacity and scale-up status with each producer, and set contingency plans for supply interruptions, including a qualified second source, because switching strains can mean repeating safety documentation.